LM N°2/ 2024. What is the state of hyaluronic acid R&D, today and tomorrow? Michel CHERON PDt and CEO of the VIVACY Group Interview by Pr AC BENHAMOU
LM N°2/ 2024. AH'S FLAGSHIP CLINICAL APPLICATIONS. Aesthetic and functional health in gynecology and HA. Les Entretiens de L&M: Interview with Pr Pierre MARES. MULTIPOINT VAGINAL INJECTIONS OF CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF MENOPAUSAL GENITOURINARY SYNDROME (MGUS) ASSOCIATED WITH VULVOVAGINAL ATROPHY (VVA).
No More Posts
